Itchy, blistering rash from poison ivy, nickel, fragrances, or latex? Get fast online evaluation and prescription treatment — same-day appointments available in DE, MD & WA.

Board-Certified HIPAA-Compliant Same-Day Available DE · MD · WA

Book a Same-Day Visit →

Irritant vs. Allergic Contact Dermatitis — Key Differences

Contact dermatitis is an inflammatory skin reaction caused by direct skin contact with an offending substance. It is divided into two mechanistically distinct subtypes. Irritant contact dermatitis (ICD) — the more common form, accounting for 80% of cases — results from direct chemical or physical damage to the skin barrier, bypassing the immune system. Common irritants include soaps and detergents, hand sanitizers with repeated use, solvents, acids, alkalis, and prolonged water exposure. ICD tends to be confined to the area of contact and resolves with removal of the irritant and barrier restoration.

Allergic contact dermatitis (ACD) is a delayed-type (Type IV) hypersensitivity reaction mediated by sensitized T lymphocytes. Initial sensitization requires prior exposure to the allergen — subsequent exposure triggers the immune response, typically within 12–72 hours of contact. ACD can spread beyond the area of contact and can be triggered by minute quantities of the allergen. The most common allergens implicated in ACD include nickel (the most common contact allergen worldwide — found in jewelry, belt buckles, and clothing fasteners), urushiol from poison ivy, oak, and sumac; fragrances and preservatives; latex; topical antibiotics (neomycin); hair dye (p-phenylenediamine); and rubber accelerants.

our board-certified provider, evaluates contact dermatitis via telehealth using detailed exposure history and clinical photo review. The history is central to diagnosis — identifying potential allergens or irritants requires a thorough review of occupational exposures, new or changed products (soaps, lotions, detergents, jewelry), recent outdoor exposures, and the temporal relationship between exposure and rash onset. Formal patch testing — the definitive diagnostic tool for ACD — requires in-person dermatology referral and is ordered when the allergen remains unclear after clinical evaluation.

Common Contact Allergens & Presentations We Treat

Treatment — Steroids, Patch Testing & Trigger Avoidance

The mainstay of contact dermatitis treatment is twofold: remove the offending agent and suppress the inflammatory response. Topical corticosteroids — selected for appropriate potency based on body region and severity — are the primary pharmacological treatment. Mild-to-moderate presentations on the trunk and extremities respond well to mid-potency agents such as triamcinolone 0.1% cream. Severe widespread ACD — particularly from poison ivy exposure — typically requires a course of systemic oral corticosteroids. Prednisone taper protocols for severe poison ivy ACD generally begin at 40–60mg/day and taper over 14–21 days. A short taper (5–7 days) is frequently insufficient and leads to symptom rebound, as urushiol-driven ACD can persist for 2–3 weeks.

Antihistamines — particularly hydroxyzine or diphenhydramine at night — help manage the intense pruritus that accompanies ACD and improve sleep quality during flares. Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are alternatives for sensitive areas or patients who cannot use corticosteroids. Cool compresses and colloidal oatmeal baths provide additional symptomatic relief. Barrier repair with fragrance-free emollients is essential to restore the disrupted skin barrier once the acute phase resolves.

Patch testing — the 48–72 hour application of standardized allergen panels to the back under occlusion — is the definitive diagnostic test for allergic contact dermatitis when the causative allergen is not clinically apparent. Patch testing cannot be performed via telehealth and requires referral to a dermatologist or allergist with patch testing capability. your provider will refer patients with recurrent or occupation-related ACD to patch testing when indicated, with a clinical summary documenting the history, suspected allergens, and treatment response to expedite the referral.